For extended travel, patients may need to consider temperature monitoring or insulated packaging, particularly when traveling to regions with extreme climates
A critical and unresolved translational question is whether the 0.4% CSF-to-plasma ratio achieved at clinical doses is sufficient to meaningfully engage central GLP-1 receptors and activate the neuroprotective pathways described in Section 5
PMID:34464955 [18] Evans-Brown M, Dawson RT, Chandler M, McVeigh J
Advise your doctor of any medicine you take during pregnancy, particularly in your first trimester
I have a disclaimer regarding the additional benefits of GLP-1 medications that have recently been published in studies
Compounded medications are customized formulations and are not pre-approved by the FDA for safety, purity, or efficacy, and are distinct from commercially manufactured, FDA-approved medications